Celldex Therapeutics, Inc. ( CLDX) - Stock Earnings
CLDX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
CLDX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -81.4 million USD | 75000 USD |
| 2026Q1 | -78.7 million USD | 15000 USD |
| 2026Q2 | -73.5 million USD | 22000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CLDX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -141.4 million USD | 6.9 million USD |
| 2024 | -157.9 million USD | 7.0 million USD |
| 2025 | -258.8 million USD | 1.5 million USD |
| 2026 Est. | — | — |
CLDX
Price: $28.25
52 week price:
Earnings Per Share: -4.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 2.2 billion